The global medical aesthetics market is projected to reach USD 25.9 billion by 2028 from USD 15.4 billion in 2023, at a CAGR of 11.0% from 2023 to 2028. Market growth is attributed to the increasing popularity of minimally invasive and noninvasive aesthetic procedures. Patients are increasingly opting for these procedures due to their lower risks, shorter recovery times, and natural-looking results. This trend reflects a broader shift towards cosmetic treatments that offer enhanced safety and convenience, driving market expansion.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=885
Based on the product, the medical aesthetics market is segmented into facial aesthetic products, cosmetics implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals and skin lighteners, hair removal devices, tattoo removal devices, thread lift products, Physician- dispensed eyelash products and nail treatment laser devices. The facial aesthetic products segment held the largest share of medical aesthetics marketing in 2022. The increasing utilization of specialized equipment for addressing specific medical conditions and a growing awareness regarding the importance of early detection.
Based on procedures, the medical aesthetics market is segmented into surgical procedures – breast augmentation, rhinoplasty, facelift and body lift, and other surgical procedures. The non-surgical procedures- anti-aging and skin rejuvenation, tattoo and scar removal, hair removal, lipolysis, and other non-surgical procedures. Growth in this segment can be attributed to the rising demand for aesthetic procedures and increasing investments in the healthcare sector. Over the last few years, there have been significant technological developments. New advancements, updates, and the launch of technologically advanced products in this segment in the last few years are anticipated to drive the market growth.
Based on end users, the medical aesthetics market is segmented into clinics, hospitals, and medical spas, beauty centers, and home care settings. The expansion in this category can be credited to advanced technologies and increasing efforts by both government and private entities to support the development of the medical aesthetics device industry. Additionally, the rising elderly population and an increasing focus on maintaining one’s health and appearance are expected to be key drivers of market growth.
Based on region, North America accounts for the highest share of the medical aesthetics market. This is due to strategic initiatives by the market players in the region, a growing number of concerns regarding aesthetics treatment, and the aesthetics healthcare infrastructure. The US has a higher adoption rate of innovative technologies as compared to other countries, which is a major factor responsible for the large share of the US in the North American medical aesthetics market. Availability of advanced and user-friendly product are the other major factors responsible for the growth of the market.
The key players profiled in the medical aesthetics market report include Abbvie Inc. (US), Galderma (Switzerland), Johnson & Johnson (US), Bausch Health Companies Inc. (Canada), Cutera (US), and El.En. S.p.A (Italy), InMode Ltd. (Israel), Lumenis Be Ltd. (Israel), and Fotona (Slovenia), among others
Recent Developments of Medical Aesthetics Industry
- In March 2023, Galderma introduced “FACE by Galderma,” an augmented reality (AR) tool that empowers both aesthetic professionals and patients to preview injectable treatment results before the actual procedure, enhancing the treatment planning process.
- August 2022, AbbVie Inc. launched SkinMedica Firm & Tone Lotion for Body, the first product from the professional-grade skincare line formulated to prevent and address visible signs of the body.
- March 2021, Bausch Health Companies Inc. and its Solta Medical business announced the US launch of the Clear + Brilliant Touch laser, a next-generation product that delivers a customized and more comprehensive treatment protocol by providing patients of all ages and skin types with the benefits of two wavelengths.
